Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
501 W North Ave
Ste 201
Melrose Park, IL 60160Phone+1 708-450-5055Fax+1 708-338-2474
Education & Training
- Loyola University Medical CenterResidency, Urology, 1982 - 1985
- Loyola Medicine MacNeal HospitalInternship, Transitional Year, 1980 - 1981
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1980
Certifications & Licensure
- FL State Medical License 1986 - Present
- IL State Medical License 1981 - 2026
- IN State Medical License 2007 - 2025
- CA State Medical License 1990 - 2022
- American Board of Urology Urology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Salvage Cryotherapy in Recurrent Prostate Cancer Start of enrollment: 2007 Jan 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 8 citationsLow-grade prostate cancer should still be labelled cancer.Kenneth A Iczkowski, Mariel Molina, Lars Egevad, David G Bostwick, Geert J L H van Leenders
BJU International. 2022-12-01 - 17 citationsLongitudinal follow-up and performance validation of an mRNA-based urine test (Xpert® Bladder Cancer Monitor) for surveillance in patients with non-muscle-invasive bla...Barrett E. Cowan, Eric A. Klein, Ken Jansz, Karl R. Westenfelder, Timothy J. Bradford
BJU International. 2021-05-05 - Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical ...E. David Crawford, Jason Hafron, Scott T. Tagawa, Przemyslaw Twardowski, Richard G. Harris
The Journal of Urology. 2021-02-01
Press Mentions
- Prostate ProblemsMarch 14th, 2021
- Physician Groups 'Struggling to Survive' After COVID-19 — Will They Succumb to Hospital Buyouts? 4 Thoughts from Dr. Richard HarrisApril 30th, 2020
- Majority of Americans Worried About Impact of Hospital MergersDecember 4th, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: